Cyclo Therapeutics Announces Closing of Underwriters’ Option to Purchase Additional Shares of …,

The company is planning an early phase clinical trial using Trappsol ® Cyclo™ intravenously in Alzheimer’s Disease based on encouraging data from …, The company is planning an early phase clinical trial using Trappsol ® Cyclo™ intravenously in Alzheimer’s Disease based on encouraging data from …, Read More

Scroll to Top